BD was induced in male Balb/c mice (27.1 ¡À 0.9 g) with an intracranial balloon catheter inflated rapidly (<1 min) [BD]R or gradually (36 ¡À 5 min) [BD]G, and compared with sham-operated [SH] and control animals [C] (n = 6/group). Ten minutes after balloon insertion 10.4 ¡À 1.0 MBq 2-deoxy-2-[18F]-fluoro-D-glucose (18FDG) was administered intravenously and static images were performed and quantified.
Coronal, sagittal, and transaxial sections of cerebral 18FDG activity revealed significant differences when comparing [BD]R and [BD]G with [C] and [SH] animals. No significant 18FDG uptake was visually detectable in [BD]R and [BD]G.
The percentage injected dose showed significant differences between BD groups and [C] and [SH] (P < 0.0001). No significant difference was seen between [C] versus [SH] nor between [BD]R versus [BD]G (P > 0.05).
18FDG micro positron emission tomography imaging is a valuable tool to demonstrate brain functionality and can therefore be used as a surrogate test to confirm BD in mice.